Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Infusion Pump Errors Top ECRI's Annual Health-Tech Hazards List

Executive Summary

The ECRI Institute identified infusion pump errors as its number-one health-technology hazard for hospitals to look for in 2017, followed by inadequate cleaning of complex reusuable instruments, ventilator alarm management, and infection risks with heater-cooler devices.

You may also be interested in...



FDA Panel Says More Research Needed To Fight Heater-Cooler Infections

The Circulatory System Devices advisory panel generally recommends more frequent cleaning of the devices used to support open-chest surgery and, in the long term, it tasks manufacturers with redesigning them so they are easier to clean and disinfect.

Gamma Camera Failures, Telemetry Shortcomings Added To ECRI's Top Tech Hazards

Gamma camera mechanical failures and surveillance challenges with telemetry-monitored patients monitored are two risks that have been elevated to the nonprofit ECRI Institute's Top 10 technology hazards for the first time in its 2016 listing, while inadequate cleaning of flexible endoscopes and missed alarms on monitoring equipment continue to be highlighted in the annual ranking.

White House To Deliver 25 Million Face Masks To Low-Income Americans

The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT104124

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel